The Michael J. Fox Foundation for Parkinson's Research has awarded a $670,000 grant to Yesse Technologies Inc to advance its nose-on-chip platform to detect the characteristic smell linked to Parkinson's disease (PD).
University of Wisconsin-Madison researchers demonstrate a proof-of-concept stem cell treatment in a mouse model of Parkinson's disease. They suggest that neurons derived from stem cells can integrate well into the correct regions of the brain, connect with native neurons and restore motor functions.
Rehab approaches depend on symptoms presented by the patient and functional deficits assessed by a clinician, according to Saloni Agarwal, PT, author of this feature for Rehab Management.
Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson’s disease and essential tremor may lead to better outcomes without surgery and with less risk of negative effects, a new study led by UT Southwestern researchers suggests.
Read More
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces that Bill Rasmussen has joined its team to help speed a cure for Parkinson’s disease.
Read More
The US Food and Drug Administration has approved Kynmobi from Sunovion Pharmaceuticals Inc, formulated to treat “off” time, when Parkinson’s disease (PD) symptoms are not well controlled with oral medication.
Read More
Reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) is technically feasible, investigators from McLean Hospital and Massachusetts General Hospital (MGH) suggest, in the New England Journal of Medicine.
Read More
The American Parkinson Disease Association (APDA) announces the full schedule for the 2020 APDA Optimism Walks — a nationwide movement to mobilize and inspire people to step up and help put an end to Parkinson’s disease (PD).
Read More
A new generation of wearables in the funnel can monitor, encourage, and even treat people suffering from chronic neurological disorders such as stroke, cerebral palsy, and even the essential tremors that come with Parkinson’s Disease. They’re small, they’re fierce, and they are all in for conquering learned non-use.
Read More
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is launching a limited-series podcast beginning Wednesday, May 6, 2020, designed to help people with Parkinson’s disease and their care partners navigate their way through the COVID-19 pandemic.
Read More
The Michael J. Fox Foundation for Parkinson’s Research has released “Together, We Can Solve the Parkinson’s Puzzle,” a new video resource to help empower patients and families to participate in Parkinson’s research.
Read More
Evidence suggests that Parkinson’s disease is partly an autoimmune disease. In addition, signs of autoimmunity can appear in Parkinson’s disease patients years before their official diagnosis, researchers from La Jolla Institute for Immunology suggest in Nature Communications.
Read More
Researchers from Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital report they may have found the brain cell that triggers tremor and how to control it.
Read More
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launches its fourth annual Fox Trot 5K Run/Walk Series, a series of eight community events across the United States in support of a cure for Parkinson’s disease.
Read More
MedRhythms announces the advancement of its pipeline of neurologic rehabilitation products in multiple sclerosis (MS) and Parkinson’s disease (PD).
Read More
Researchers from Florida Atlantic University’s College of Engineering and Computer Science, in collaboration with the Icahn School of Medicine at Mount Sinai and the University of Rochester Medical Center, are teaching machines to evaluate tremor severity in Parkinson’s disease patients, they report.
Read More
Researchers propose a new diagnostic testing method for Parkinson’s disease that involves computer keystroke time rather than gait and balance.
Read More
Chaperone proteins in human cells dynamically interact with the protein α-Synuclein, which is strongly associated with Parkinson’s disease. A disturbed relationship to these “bodyguards” leads to cell damage and the formation of Lewy bodies typical for Parkinson’s disease, according to researchers from the University of Basel’s Biozentrum and published in Nature.
Read More